GRAY WILLIAM GARRETT 4
4 · Checkpoint Therapeutics, Inc. · Filed Mar 1, 2024
Insider Transaction Report
Form 4
GRAY WILLIAM GARRETT
Chief Financial Officer
Transactions
- Sale
Common Stock
2024-02-28$2.07/sh−2,035$4,212→ 145,224 total
Footnotes (3)
- [F1]In connection with the vesting of 3,925 shares, these shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Gray's tax withholding obligations. Mr. Gray had no discretion with respect to such sale, which was transacted automatically in accordance with the Company's corporate policies regarding the vesting of restricted stock.
- [F2]Represents the weighted average price of the shares sold in this transaction. The range of prices for such transaction was $2.07 to $2.075. The reporting person undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price.
- [F3]Includes shares of restricted common stock, which vest over various time periods.